While offering advantages like faster recovery and high patient satisfaction, cryoablation for the treatment of early-stage breast cancer is still under investigation for effectiveness and requires ...

Earlier analyses demonstrated strong local tumor control, with nearly nine in 10 patients remaining free of recurrence at ...

Please provide your email address to receive an email when new articles are posted on . Patients who received cryoablation as treatment for breast cancer had low recurrence rate after 16 months.

Certain cancers can now be frozen inside your body. Yes, you heard it right. In what could be a significant leap in minimally invasive oncology, Liverpool Hospi ...

The authors noted that cryoablation allows rapid recovery without major complications, making it particularly suitable for elderly patients and those considered unfit for surgery. They also ...

Women with early-stage breast cancer who couldn't enter clinical trials of cryoablation because of "unfavorable" tumor or patient characteristics nevertheless enjoyed a high rate of treatment success ...

IceCure Medical Ltd. (NASDAQ:ICCM), the developer of minimally invasive cryoablation technology that destroys tumors by freezing them, was granted marketing authorization from the U.S. Food and Drug ...

Please provide your email address to receive an email when new articles are posted on . XSense Cryoablation System with CryoProbes is cleared for general minimally invasive cryoablation. The system ...

CAESAREA, Israel, Oct. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration ("FDA") has granted marketing authorization for ProSense®, a minimally invasive cryoablation treatment for patients ...